title: Localized lipoatrophy after prolonged treatment with copolymer 1.
authors.forename: G L
authors.initials: GL
authors.lastname: Mancardi
authors.forename: A
authors.initials: A
authors.lastname: Murialdo
authors.forename: F
authors.initials: F
authors.lastname: Drago
authors.forename: C
authors.initials: C
authors.lastname: Brusati
authors.forename: R
authors.initials: R
authors.lastname: Croce
authors.forename: M
authors.initials: M
authors.lastname: Inglese
authors.forename: S
authors.initials: S
authors.lastname: Ratto
mesh_terms: D000273:Adipose Tissue / Q000473:pathology*; D000328:Adult; D001284:Atrophy; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007279:Injections, Subcutaneous; D007866:Leg / Q000473:pathology; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate